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Regional differences in the temporal expression of 
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Although caspases have been intimately linked to apoptotic events, some of the pro-apoptotic 
caspases also may regulate differentiation. We previously demonstrated that active caspase-3 
is expressed and has an apparent non-apoptotic function during the development of cerebellar 
Bergmann glia. The current study seeks to further correlate active/cleaved caspase-3 expression 
with the developmental phenotype of Bergmann glia by examining regional differences in the 
temporal pattern of expression of cleaved caspase-3 immunoreactivity in lobules of the cerebellar 
vermis. In general, we found that the expression pattern of cleaved caspase-3 corresponds to 
the reported developmental temporal proﬁ  le of the lobes and that its levels peak at 15 days 
and declines thereafter. Compared to intermediate or late maturing lobules, early maturing 
lobules had higher levels of active caspase-3 at earlier postnatal times. This period of postnatal 
development is precisely the time during which Bergmann glia initiate differentiation.
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2002; Murray et al., 2008). Additional involvement of caspase-3 
in differentiation was observed in forebrain neurons (Yan et al., 
2001), trophoblast differentiation, syncytial fusion, and trophoblast 
turnover in human placenta (Huppertz et al., 1999). In each of these 
processes, expression of caspase-3 was transient and only portions 
of the apoptotic machinery were utilized during the differentiation 
process. The involvement of caspases in differentiation may relate 
to a subset of apoptotic-like morphological changes in cellular state 
that involve cytoskeletal rearrangements, changes in cell adhesion 
and differential transcriptional regulation (Fischer et al., 2003). 
In further support of a role of cleaved caspase-3 in differentia-
tion, neurosphere cultures generated from striatum of CD1 murine 
embryos were treated with the peptide inhibitor z-DEVD-fmk caus-
ing failure to differentiate into neurons, glia or oligodendrocytes. 
Moreover, similar neurospheres obtained from caspase-3 null mice 
also failed to differentiate and continued to express the early neural 
progenitor marker nestin (Fernando et al., 2005). Caspases also 
have been reported to function in synaptic plasticity (Dash et al., 
2000; Mattson and Duan, 1999). It is signiﬁ  cant that many cytoskel-
etal and membrane proteins are substrates for caspase-3, including 
actin (Kayalar et al., 1996; Mashima et al., 1997), spectrin (Wang 
et al., 1998), fodrin (Martin et al., 1995), and vimentin (Hashimoto 
et al., 1998; van Engeland et al., 1997). Proteolysis of these various 
proteins could be responsible for cytoskeletal changes associated 
with differentiation and may constitute the basis for the involve-
ment of caspases during development.
We previously demonstrated that active caspase-3 expression was 
not limited to neuronal cells but also was located in Bergmann glia 
of the postnatal cerebellum (Oomman et al., 2005, 2006). Bergmann 
INTRODUCTION
Although caspase-3 is one of the key executioners of apoptosis 
(Hirata et al., 1998), our lab serendipitously revealed, utilizing 
morphological and biochemical techniques, a non-apoptotic role 
for the active form of caspase-3 in differentiation of cerebellar cells 
(Oomman et al., 2004). In support of our ﬁ  ndings, there are a few 
additional reports that suggest caspases may inﬂ  uence proliferation 
and differentiation of cells (Fischer et al., 2003; Los et al., 2001). 
Proliferation of T cells is inhibited by caspase inhibitors (Alam et al., 
1999; Kennedy et al., 1999; Woo et al., 2003). In this regard, Wee1, 
an inhibitor of the G2/M cell cycle checkpoint machinery leading 
to cell cycle arrest and p21 and p27, two cyclin-  dependent kinases 
that serve as negative regulators of G1-phase cell cycle progression, 
are substrates of caspases. Thus, cleavage by caspase of any of the 
three pro-differentiation proteins promotes cell progression/prolif-
eration (Fischer et al., 2003). Caspase activation has been reported 
to abort or promote incomplete apoptosis in various blood cells 
(DeBotton et al., 2002; Zermati et al., 2001), keratinocytes (Weil 
et al., 1999), macrophages (Sordet et al., 2002), lens ﬁ  ber cells 
(Ishizaki et al., 1998) and skeletal muscle cells (Fernando et al., 
2002). The enucleation observed in keratinocytes and lens ﬁ  ber 
cells during development appear to represent such an incomplete 
apoptotic process (Ishizaki et al., 1998; Weil et al., 1999), whereas 
in the case of erythrocyte formation, caspase inhibitors suppressed 
the nuclear extrusion process and erythrocyte formation (De Maria 
et  al., 1999; Zermati et  al., 2001). Caspase activation has been 
 associated with thrombopoiesis, fragmentation of proplatelets from 
megakaryocytes (DeBotton et al., 2002), and the  differentiation of 
macrophages (Sordet et al., 2002) and muscle cells (Fernando et al., 
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glia function as developmental organizers of the cerebellar cortex to 
orchestrate the normal anatomical arrangement of Purkinje neu-
rons and their dendrites and to ensure the survival of granule cells. 
We demonstrated that cleaved caspase-3 expression in Bergmann 
glia is highest when glia are undergoing maximum differentiation/
transformation (Oomman et al., 2005). Concerning Bergmann glia 
development, it has known that Bergmann glial precursors take the 
form of radial cells at E14 (Yamada and Watanabe, 2002). These glia 
precursor cells show active migration along with the Purkinje cells 
from E16–E19. In the primitive cerebellum, premature Bergmann 
glia are evenly arranged within the Purkinje cell layer by the ﬁ  rst 
postnatal week. At the beginning of the second postnatal week, glial 
production shifts from the ventricular zone to local proliferation 
(Yamada and Watanabe, 2002) and in addition, cells by this time 
acquire a unipolar shape. From P7–P30 Bergmann glia undergo a 
transformation mainly affecting the ﬁ  bers, where the simple glial 
palisade acquires lateral appendages that resemble a reticular mesh-
work (Altman, 1975; Das, 1976; Rakic, 1971; Shiga et al., 1983). 
Glial ﬁ  ber arborization coincides with Purkinje cell dendritogenesis, 
resulting in ensheathing of the parallel ﬁ  ber-Purkinje cell synaptic 
cleft and also in ensheathing of the non-synaptic neuronal excres-
cences to form glial caps (Grosche et al., 2002).
Through immunolabeling for glial markers using glutamate/
aspartate transporters (Glast), 3-phosphoglycerate dehydrogenase, 
brain lipid binding protein (BLBP) and glutamine synthetase, it is 
known that the lobules within the cerebellum have different devel-
opmental temporal proﬁ  les (Altman, 1969) and that this proﬁ  le cor-
relates with the development of Bergmann glia (Shiga et al., 1983). 
The purpose of the present study was to evaluate regional differ-
ences in the temporal pattern of expression of cleaved   caspase-3 
immunoreactivity in the various lobules of the vermis in order to 
further correlate cleaved caspase-3 expression with the developmen-
tal   phenotype of Bergmann glia and   ultimately to its function.
MATERIALS AND METHODS
MATERIALS
Antibodies speciﬁ  c for the active cleaved form of caspase-3 (rabbit 
polyclonal antibody, catalog No. 9661L, Cell Signaling Technology, 
Beverly, MA, USA), S-100b (mouse monoclonal antibody, catalog 
No. S-2532, Sigma-Aldrich, St. Louis, MO, USA), GFAP (mouse 
monoclonal antibody, catalog No. G3893, Sigma-Aldrich), Glast 
(rabbit polyclonal antibody, catalog No. ab416-200, AbCam, 
Cambridge, MA, USA), and calbindin D28K (N-18) (goat poly-
clonal antibody, catalog No. SC-7692, Santa Cruz, Santa Cruz, CA, 
USA) were used. Donkey anti-rabbit, anti-mouse and anti-goat 
secondary antibodies linked to ﬂ  uorescent tags, Alexa 488, Alexa 
546 and Alexa 633, and Prolong Antifade mounting medium were 
obtained from Molecular Probes (Invitogen, Eugene, OR, USA).
EXPERIMENTAL ANIMAL PREPARATION AND TISSUE SLICING
Postnatal 9- to 30-day-old rats (Sprague-Dawley strain, Sasco Labs) 
of either sex were used in these studies. Rats were either decapitated 
or anesthetized with sodium pentobarbital prior to the intracardiac 
perfusion of heparin/saline (1:1000 U) followed by direct ﬁ  xation 
with 4% paraformaldehyde. Following ﬁ  xation, the cerebellum 
was removed and placed in paraformaldehyde overnight and then 
placed in 30% sucrose in phosphate buffered saline (PBS, pH 7.4) 
to cryoprotect prior to sectioning with a cryostat. Twelve micron 
sagittal vermal sections were retrieved for immunohistochemi-
cal analyses. Each experiment used a minimum of three animals 
per age [Postnatal day (P)9, P15, P21,and P30] from which one 
cerebellar slice was taken at the same region of the vermis. The 
methods employed in this study have been approved by TTUHSC 
Animal Care and Use Committee (ACUC) and conform to NIH 
guidelines.
IMMUNOHISTOCHEMICAL ASSESSMENTS
Sections were immunohistochemically stained for the presence 
of cleaved caspase-3, calbindin D28K, GFAP, Glast, and S-100b. 
Sections were washed in PBS (pH 7.4), treated with acetone 
(−20°C) for 10 min to enhance antigenicity followed by three 
rinses in PBS, and permeabilized with Triton X-100 (0.5%) over-
night at 4°C. The following day, sections were treated with a 
blocking solution (PBS containing 10% normal donkey serum 
and 0.5% Triton X-100) for 1 h. After ﬁ  ve rinses in PBS, sections 
were exposed overnight to primary antibody solution contain-
ing 10% normal donkey serum and 0.5% Triton X-100 in PBST 
(PBS in 0.1% Tween 20 and 0.5 M NaCl) on a rotating stand at 
4°C. Primary antibody concentrations were as follows: caspase-3 
(17/20 kDa fragment, 1:50), calbindin D28k (1:100 dilution), 
GFAP (1:500), Glast (1:100), and S-100b (1:200). Following the 
removal of the primary antibodies, sections were rinsed three 
times in PBS and then treated with secondary antibodies (1:250 
dilution of Alexa dye labeled donkey anti-mouse, anti-rabbit, 
anti-goat secondary antibody in PBST containing 0.1% Triton 
X-100 and 10% normal donkey serum). For triple labeling, slices 
were exposed to three primary antibodies simultaneously fol-
lowed by three secondary antibodies using our standard pro-
tocol (Oomman et al., 2004, 2005). Sections were dehydrated 
with increasing concentrations of alcohol and mounted on slides 
with non-ﬂ  uorescent antifade medium for viewing. Negative 
controls (omission of primary antibody) consistently were 
included in each experiment in order to subtract background 
autoﬂ  uorescence.
To determine the total number of Bergmann glia for the calcula-
tion of percentage of glia that contain caspase-3 immunoreactiv-
ity, slices were triple stained with cleaved caspase-3, calbindin-28k 
to identify Purkinje neurons, and S-100b to identify surrounding 
Bergmann glia. Previously, our lab and others have reported that 
S-100b selectively labels the rod-like processes and reticular proc-
esses of cerebellar Bergmann glia in the cerebellum, positioned in 
the vicinity of Purkinje neurons (Hachem et al., 2007; Oomman 
et al., 2004, 2005). Since Bergmann glia are known to surround 
Purkinje cells, we used this triple label to distinguish them and 
quantitate them based upon their size, location, and immunohis-
tochemical selectivity.
CONFOCAL MICROSCOPY
Images were obtained using a Zeiss LSM 510 Meta Axioplot 2 laser 
scanning confocal imaging system equipped with Helium–Neon 
lasers, coupled to a Zeiss inverted microscope with X60 or X25 
oil immersion objectives, using dichroic HFT UV/488/543/633 
for conventional laser lines. The imaging system was controlled 
by LSM 510 META software (version 3.2, Carl Zeiss, Thornwood, Frontiers in Neuroanatomy  www.frontiersin.org  May  2009 | Volume  3 | Article  3 | 3
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NY, USA). Images were recorded at 488-nm excitation using a 
BP 510–520 IR band pass ﬁ  lter for Alexa Fluor 488, at 543-nm 
excitation using a BP 565–615 IR pass ﬁ  lter for Alexa 546, and at 
633-nm excitation and a BP 644–676 meta ﬁ  lter for Alexa 633. 
The pinhole size was adjusted to obtain the optimal spatial resolu-
tion and high-magniﬁ  cation images were recorded with a 0.08 µm 
x/y pixel size. A rigorous lambda mode analysis using the META 
function provided excitation and emission spectra of each dye to 
optimize ﬁ  lter conﬁ  guration. Settings of the confocal microscope 
were optimized for imaging each experiment and then equivalently 
applied to all sections. Laser power and PMT gain were adjusted 
to ensure that even the brightest ﬂ  uorescence was below satura-
tion (16 bit). Glial cells were chosen in similar regions within each 
lobule and scanned at 1024 × 1024 pixel resolution.
STATISTICAL ANALYSES
Statistical analyses were performed using PSI-Plot (Poly Software 
International, Pearl River, NY, USA) or Sigma Stat (SPSS Science, 
Chicago, IL, USA). Data are expressed as mean (±SEM). To compare 
two groups, a Mann–Whitney Rank Sum Test for non-parametric 
data was used. P ≤ 0.05 was considered signiﬁ  cant.
RESULTS
To test for the speciﬁ  city of the active caspase-3 antibody, a prea-
bsorption assay was performed with a caspase-3 blocking peptide 
(No. 1050; Cell Signaling Technology). The blocking peptide con-
tains the amino acid sequence present in the carboxy-  terminus of 
the catalytic subunit (from amino acids 165 to amino acids 175; 
human caspase  3). Figure 1A (inset) demonstrates the lack of 
  immunoreactivity in the slice when exposed to the primary anti-
body that had been preabsorbed with the blocking peptide. This 
panel shows an adjoining section labeled for active caspase-3 
without the antigen preabsorption step from the same experi-
ment. Western blots were run in cells treated with a pro-apoptotic 
stimulus (cytochrome C) to verify the speciﬁ  city of the polyclonal 
antibody used in these studies (Figure 1B). In addition, we have 
utilized a cleaved caspase-3 monoclonal antibody obtained from 
Cell Signaling (5A1E, catalog No. 9664) to compare labeling of 
Bergmann glia with the polyclonal derived cleaved caspase-3 anti-
body labeling (Figures 1C,D).
Figures 2A–C illustrate that cells immunoreactive-positive for S-
100b and cleaved caspase-3 are situated as classic Bergmann glia sur-
rounding the calbindin-positive Purkinje neurons. S-100b- positive 
cells also co-labeled for cleaved caspase-3 immunoreactivity in the 
nuclei rather than cytosol, suggesting a unique role related to nuclear 
function. We conﬁ  rmed the apparent authenticity of the S-100b-
labeled cells as Bergmann glia by performing additional immuno-
histochemical studies using antigens known to localize to Bergmann 
glia, including Glast, and GFAP (Feng et al., 1994; Kuhar et al., 1993). 
As seen with S-100b, GFAP  colocalized with cleaved caspase-3 in the 
same cells that co-labeled with Glast and S-100b (Figures 2D,E). 
Figure 2F is a modiﬁ  ed image (original active   caspase-3 labeled 
as green ﬂ  uorescence merged with enhanced Purkinje neuron 
autoﬂ  uorescence labeled as red ﬂ  uorescence) which clearly dem-
onstrates the close proximity of these cells to Purkinje neurons. In 
Figure 2F, to visualize Purkinje neurons, autoﬂ  uorescence derived 
from endogenous, intrinsic ﬂ  uorophores such as NADPH and ﬂ  avin 
coenzymes present in mitochondria and lysosomes was intensiﬁ  ed 
by increasing the gain of the microscope detector. Our lab previ-
ously demonstrated (Oomman et al., 2005, 2006) that the S-100b 
labeled cells failed to label with postmitotic neuronal markers TUJ1, 
a beta III tubulin cytosolic marker (Cameron and McKay, 2001; 
Yan et al., 2001), and NeuN, a neuron-speciﬁ  c neuronal marker 
(Hoshimaru et al., 1996; Yan et al., 2001), further verifying the active 
caspase-positive cells are not neurons.
Bergmann glia immunopositive for S-100b and GFAP, two 
markers of glia maturation (Boyes et al., 1986; Tramontina et al., 
2002), showed a strong co-labeling with active caspase-3, suggesting 
a link between the degree of differentiation as indexed by the marker 
proteins S-100b and GFAP, and the presence of active caspase-3. 
Furthermore, quantitation of the S-100b immunohistochemical 
ﬂ  uorescent intensity within the processes of the Bergmann glia 
that were immunopositive for cleaved   caspase-3 compared to the 
S-100b immunoreactivity in non-caspase-3 labeled Bergmann glia 
revealed signiﬁ  cant differences (P ≤ 0.05) between the two groups. 
S-100b immunoreactivity obtained from Bergmann glia processes 
in caspase-3 containing glia in 9-, 15-, and 21-day-old rats were 
signiﬁ  cantly higher by 54, 50 and 48%, respectively than the non-
caspase-3 containing glia, suggesting the presence of nuclear active 
caspase-3 enhanced expression of a cytosolic marker of Bergmann 
glia maturation.
We determined the percentage of Bergmann glia that expressed 
cleaved caspase-3 immunoreactivity in all lobules at each of the 
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FIGURE 1 | Panel (A) demonstrates a cerebellar section treated in the 
absence of blocking peptide, and the inset shows an adjacent section treated 
after co-incubating the antibody with the blocking peptide. As noted, the 
blocking peptide completely prevented the ability of the antibody raised 
against the cleaved form of caspase-3 to recognize cleaved caspase-3 in 
Bergmann cells. Faintly stained cells are presumed epithelial cells. Panel (B) is 
a Western blot analysis of extracts from HeLa cells treated with cytochrome c 
(0.25 mg/ml in vitro) using the cleaved polyclonal caspase-3 antibody to 
demonstrate the antibody speciﬁ  city. The left hand column is molecular 
weight markers, and the right hand column shows authentic cleaved caspase-
3 at 17 and 19 kDa. Panels (C) and (D) illustrate cultured Bergmann glia co-
labeled with either a polyclonal (C) or monoclonal (D) antibody for cleaved 
caspase-3 (red, Alexa 594), and TU-01 (green, Alexa 488), an antitubulin 
antibody that selectively labels Bergmann glia. Note the consistent nuclear 
label for cleaved caspase-3.Frontiers in Neuroanatomy  www.frontiersin.org  May  2009 | Volume  3 | Article  3 | 4
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FIGURE 2 | Panels (A) and (B) are ﬂ  uorescently labeled images from 
15-day-old cerebellum using cleaved caspase-3 and S-100b 
immunohistochemistry visualized with Alexa 488 and Alexa 546, respectively. 
It is apparent that caspase-3 labels the nuclei of Bergmann glia. Asterisks 
identify the Bergmann glia in which approximately 60% contain cleaved 
caspase-3 immunoreactivity. Panel (C) is the triple labeled ﬂ  uorescent image 
of caspase-3 (Alexa 488), S-100b (Alexa 546) and calbindin (Alexa 633) to 
identify and quantitate the total number of Bergmann glia within each lobule 
at the different ages, surrounding the Purkinje neurons. Panel (D) is a double 
labeled image using cleaved caspase-3 and GFAP immunoreactivity 
(visualized with Alexa 488 (green) and Alexa 546 (red), respectively). In Panel 
(E) cells are double labeled with S-100b (red ﬂ  uorescence) and Glast (green 
ﬂ  uorescence), two markers of Bergmann glia, respectively, to further verify 
the presence of caspase-3 in the nuclei of Bergmann glia surrounding Purkinje 
neurons obtained from 15-day-old cerebellum. Panel (F) is a modiﬁ  ed image 
of an original cleaved caspase-3 labeling visualized with green wavelength 
using a Alexa 488 ﬂ  uorescent dye coupled with an auto-ﬂ  uorescent label of 
the tissue at the red wavelength (594 nm), showing the location of 
immunoreactive cells within the Purkinje cell layer in a 21-day-old cerebellum. 
P – Purkinje cell; B – Bergmann glia; ML – molecular layer.
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FIGURE 3 | Caspase-3 immunoreactivity varies with age in the cerebellar 
vermis. Panel (A) is a graph that depicts the percentage of Bergmann glia 
expressing cleaved caspase-3 as a function of the developmental age of the rat. 
Panel (B) is an example of a vermal sagittal cerebellar slice from a 21-day-old rat 
stained with Toluidine blue to depict the classiﬁ  cation used to characterize the 
various lobules. Panel (C) is a comparison of the expression of caspase-3 
immunoreactivity in Bergmann glia in the early vs. intermediate/late maturing 
lobules of the cerebellar vermis.Frontiers in Neuroanatomy  www.frontiersin.org  May  2009 | Volume  3 | Article  3 | 5
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initiated differentiation at this time period compared to the later 
developing posterior lobe (with more Bergmann glia still in the 
stage of proliferation). At P21–P30, Bergmann glia in the anterior 
lobe would be near terminal stages of differentiation, and thus 
require less cleaved caspase-3; whereas those in the later develop-
ing posterior lobe would be near initiation of differentiation, and 
therefore require higher levels of caspase-3 as our data show. At 
P30, only 20% of Bergmann glia in both regions of the cerebellum 
continued to express cleaved  caspase-3, suggesting that because dif-
ferentiation of Bergmann glia in all lobules had plateaued compared 
to the earlier time periods, the functional requirement for active 
caspase-3 was diminished. Since cell production is thought to cease 
by the end of the ﬁ  rst postnatal month, the appearance of cleaved 
caspase-3 in cells up to P60 was intriguing. Classic understanding 
of cerebellar development holds that the mammalian cerebellum 
does not appear to engage in persistent neurogenesis after the end 
of postnatal granule cell genesis. However, the cerebellum is the only 
CNS area where radial glia cells, the type of cell that corresponds 
to the embryonic neural progenitor cells (Anthony et al., 2004), 
exist in the adult. Furthermore, as also seen in the hippocampus, 
stem cells have been identiﬁ  ed in the adult cerebellum suggest-
ing the continued capacity for cellular proliferation (Klein et al., 
2005; Lee et al., 2005). Additionally, Ponti et al. (2008) observed the 
presence of a proliferative subpial layer in the rabbit cerebellum 
that replaces the external granule cell layer between the fourth and 
ﬁ  fth postnatal week. This layer persists from postnatal day 40 to 
150 and participates in the proliferation of Bergmann glia in the 
Purkinje cell layer as evidenced by the presence of BrdU, Brain Lipid 
Binding Protein (BLBP) and Sox2-positive nuclei. Interestingly, the 
transcription factors Sox1, a known marker of early neural progeni-
tors (Aubert et al., 2003; Barraud et al., 2005; Li et al., 2001), Sox2 
and Sox9, known to be molecular markers of adult neural stem 
cells (Ellis et al., 2004; Episkopou, 2005; Sottile et al., 2006), were 
located in the adult cerebellar Bergmann glia of rodents (Sottile 
et al., 2006), suggesting that Bergmann glia may represent stem 
cells in the adult cerebellum. Additionally, recent evidence has 
emerged to suggest the existence of a ﬁ  fth cellular element in the 
brain known as NG2 glia or synantocytes (Butt et al., 2005). These 
cells reside in the location of Bergmann glia and retain the capac-
ity to proliferate and differentiate throughout adulthood (Levine 
et al., 1993). Future studies need to further address the potential 
of glia-genesis in peripuberal and adult rats and the potential role 
of caspase-3 in these cells.
Our earlier report indicated that cleaved caspase-3 immuno-
reactivity was more frequently seen in non-proliferating (Ki67-
  negative) than in proliferating Bergmann glia (Ki67-positive) 
(Oomman et al., 2005, 2006). The expression trend of cleaved 
caspase-3 immunoreactivity in Bergmann glia and the lack of 
co-labeling with Ki67 suggest that caspase-3 expression does not 
correlate with the temporal period of proliferation. Our present 
data demonstrate that levels of cleaved caspase-3 expression in 
Bergmann glia are highest at P15–P21 when they initiate differ-
entiation/transformation that includes the formation of lateral 
expansions protruding from the proximal shaft of Bergmann  ﬁ  bers 
(Shiga et al., 1983). Additionally, we have previously shown that 
cleaved caspase-3 colocalizes with BLBP, which is a marker for 
Bergmann glia that have undergone differentiation (Oomman 
 developmental ages (P9, P15, P21, and P30). As indicated in Figure 3A, 
we found that Bergmann glia in all vermal lobules expressed peak 
caspase-3 immunoreactivity at P15, in which approximately 35% 
of Bergmann glia expressed positive immunoreactivity; whereas the 
lowest percentage of expression was apparent at P9. On P21 and P30, 
fewer Bergmann glia (approximately 20%) were immunoreactive for 
cleaved caspase-3, apparently attaining a plateau by day P21. Although 
active caspase-3 immunoreactivity was observed in cells lying within 
the PC layer from P8 through P65, the expression decreased markedly 
in P45 and P65 days, representing less than 5% of the BG.
To further analyze differences in the developmental expres-
sion of cleaved caspase-3 immunoreactivity in Bergmann glia, the 
cerebellum was subdivided into various lobules based upon their 
developmental proﬁ  le. We classiﬁ  ed lobules II–V as early develop-
ing, and lobules VIa-X and I as intermediate/late developing lob-
ules (Figure 3B) (Altman, 1969). As seen in Figure 3C, signiﬁ  cant 
differences in the number of Bergmann glia expressing cleaved 
caspase-3 immunoreactivity were apparent at all the develop-
mental ages except P30. Speciﬁ  cally, the earlier developing lobules 
expressed a higher mean percentage of cleaved caspase-3-positive 
Bergmann glia at P9 compared to the intermediate/late lobules, 
attaining the highest expression at P15; whereas, the intermediate 
and later developing lobules expressed a higher percentage at P15 
and P21. By P30, the percentages of Bergmann glia in both regions 
exhibiting expression of cleaved caspase-3 were similar.
DISCUSSION
It is well known that cleaved caspase-3 is instrumental in the exe-
cution of morphological and biochemical features associated with 
apoptosis. Speciﬁ  cally, it has been shown to act in an executive role 
in nuclear apoptosis by activating downstream factors that disas-
semble nuclei (Jänicke et al., 1998; Samejima et al., 1999; Woo et al., 
1998), after turning off a number of critical pathways that promote 
cell survival (Samejima and Earnshaw, 1998). However, in our previ-
ous study, the potential apoptotic fate of active caspase-3-positive 
Bergmann glia was ruled out based on the failure to correlate the 
co-expression of cleaved caspase-3 immunoreactivity with markers 
of apoptosis that included: Annexin V (exclusion of phosphatidyl-
serine exposure), terminal deoxynucleotidyl   transferase-mediated 
biotinylated UTP nick end labeling (TUNEL to detect DNA frag-
mentation), and DNA compaction (TOPRO-3) (Oomman et al., 
2005). Speciﬁ  cally, we reported that more than 90% of the active 
caspase-3-positive cells lacked co-labeling for one of these apoptotic 
markers, providing evidence for a role of cleaved caspase-3 inde-
pendent of classical apoptosis (Oomman et al., 2005).
In the present study, the expression pattern of cleaved caspase-3 in 
the anterior and posterior lobes of the cerebellar vermis corresponds 
to the reported developmental proﬁ  le of these lobes. Speciﬁ  cally, 
the anterior lobe expressed a higher percentage of cleaved caspase-
3 immunoreactive Bergmann glia compared to the posterior lobe 
at P9. Previous reports indicate that the anterior lobes of the vermis 
are an earlier developing region of the  cerebellum compared to the 
posterior lobe that represents the intermediate and late develop-
ing lobes (Oomman et al., 2005). If nuclear caspase-3 has a role in 
promoting differentiation, then the observed earlier expression of 
cleaved caspase-3 at P9 in the lobules in the anterior lobe could 
indicate that a higher  percentage of Bergmann glia  presumably have Frontiers in Neuroanatomy  www.frontiersin.org  May  2009 | Volume  3 | Article  3 | 6
Finckbone et al.  Regional differences in non-apoptotic caspase-3 in Glia
et al., 2005, 2006). Additional studies in our lab using cultured 
Bergmann glia have shown that the caspase-3 peptide inhibitor, 
DMQD-fmk (80 µM) caused an almost threefold increase in the 
number of proliferating precursor glial cells and decreased the 
number of differentiating Bergmann glia, without signiﬁ  cantly 
altering the non-glial active caspase-3-negative population. That 
is, caspase-3 inhibition arrested Bergmann glia differentiation and 
caused reversion to a proliferative state (Oomman et al., 2006). 
The transformation in the developmental state of Bergmann glia 
occurring after suppression of caspase-3 activity strongly sug-
gests an involvement of this enzyme in promoting differentia-
tion of Bergmann glia, possibly by allowing cells to exit the cell 
cycle. Therefore in this context, active caspase-3 could be a genetic 
manipulator playing a key role in controlling spatially distant and 
dynamic events like glial morphogenesis and arborization, and 
maintaining the differentiated state of the cell. In this regard, 
numerous substrates have been linked to cleaved caspase-3 and 
in the case of nuclear proteins, the involvement of transcription 
factors and cell cycle proteins may be of relevance to the initiation 
of differentiation (Fischer et al., 2003). Future studies need to be 
directed at identifying the cellular cascade and substrates utilized 
in this novel non-apoptotic function.
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